Community Matters in Multiple Sclerosis
30 MAR 2023
At EMD Serono, we have a long-standing legacy in neurology and immunology, with vast R&D and commercial experience in multiple sclerosis over more than 20 years. This MS Awareness Month is the perfect opportunity to recognize our heritage and commitment to the community.
For the nearly 1 million people in the U.S. living with multiple sclerosis (MS),1 being diagnosed with this chronic and unpredictable disease can feel discouraging, confusing, isolating, and scary.
Patient support has been a hallmark of our efforts, as our care for those impacted by MS extends beyond our therapies.
From our MS LifeLines in-house patient support call center, to our collaboration with advocacy partners like the National MS Society, to our recent “Express4MS” campaign designed to give visibility to the journeys faced by people living with MS – we have been at the forefront of patient-directed care and support.
Our ongoing connection to the community has led to programming designed to advance treatment methods and research in the MS space:
- Our MS Link initiative brings together an interdisciplinary community of MS stakeholders to form a top-tier scientific research network focused on sustainable transformation of MS care and on cooperative work in the areas of real-world data and patient reported outcomes;
- MS in the 21st Century, which is a unique group comprised of MS patients and healthcare professionals working together to improve communication and create resources to facilitate mutual understanding in MS care; and
- Our I’M IN program explores solutions to improve diversity, equity, and inclusion (DEI) with physicians and healthcare professionals in our shared ecosystem. We’ve taken important steps toward increasing DE&I in medical offices by becoming the first company to support and fund national fellowships dedicated to reducing disparities in neurological care for MS patients.
Over our time in the MS space, significant advances have been made in treatment options to address relapses for those impacted by MS. Yet there is more work to be done, which is why we continue to invest in the science.
Educating those across the medical field remains critical. Additionally, our R&D teams continue to explore new therapeutic approaches and ride the waves of innovation. We remain steadfast in our support of the community to help create, improve and prolong lives.
Read more real-life patient experiences and how to better “express yourself” by visiting Express4MS.com.